Phagocytosis of Erythrocytes from Gaucher Patients Induces Phenotypic Modifications in Macrophages, Driving Them toward Gaucher Cells.
Gaucher disease
erythrophagocytosis
macrophages
red blood cells
Journal
International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791
Informations de publication
Date de publication:
11 Jul 2022
11 Jul 2022
Historique:
received:
31
05
2022
revised:
05
07
2022
accepted:
05
07
2022
entrez:
27
7
2022
pubmed:
28
7
2022
medline:
29
7
2022
Statut:
epublish
Résumé
Gaucher disease (GD) is caused by glucocerebrosidase deficiency leading to the accumulation of sphingolipids in macrophages named "Gaucher's Cells". These cells are characterized by deregulated expression of cell surface markers, abnormal secretion of inflammatory cytokines, and iron sequestration. These cells are known to infiltrate tissues resulting in hematological manifestations, splenomegaly, and bone diseases. We have already demonstrated that Gaucher red blood cells exhibit altered properties suggesting their key role in GD clinical manifestations. We hypothesized that Gaucher's erythrocytes could be prone to premature destruction by macrophages contributing to the formation of altered macrophages and Gaucher-like cells. We conducted in vitro experiments of erythrophagocytosis using erythrocytes from Gaucher's patients or healthy donors. Our results showed an enhanced erythrophagocytosis of Gaucher red blood cells compared to healthy red blood cells, which is related to erythrocyte sphingolipids overload and reduced deformability. Importantly, we showed elevated expression of the antigen-presenting molecules CD1d and MHC-II and of the iron-regulator hepcidin in macrophages, as well as enhanced secretion of the pro-inflammatory cytokine IL-1β after phagocytosis of GD erythrocytes. These results strongly suggested that erythrophagocytosis in GD contribute to phenotypic modifications in macrophages. This present study shows that erythrocytes-macrophages interactions may be crucial in GD pathophysiology and pathogenesis.
Identifiants
pubmed: 35886988
pii: ijms23147640
doi: 10.3390/ijms23147640
pmc: PMC9319206
pii:
doi:
Substances chimiques
Cytokines
0
Sphingolipids
0
Iron
E1UOL152H7
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Subventions
Organisme : Laboratory of Excellence GR-Ex
ID : ANR-11-LABX-0051
Références
Mol Genet Metab. 2017 Nov;122(3):19-27
pubmed: 28947349
Aging Cell. 2016 Feb;15(1):77-88
pubmed: 26486234
Int J Cancer. 1980 Aug;26(2):171-6
pubmed: 6970727
Br J Haematol. 2005 Jun;129(5):667-76
pubmed: 15916690
Am J Hematol. 1991 Oct;38(2):130-7
pubmed: 1951303
Mt Sinai J Med. 1970 Jul-Aug;37(4):404-17
pubmed: 4194895
Transfusion. 2003 Feb;43(2):157-64
pubmed: 12559010
Biochimie. 1998 Feb;80(2):173-95
pubmed: 9587675
Nat Commun. 2021 Feb 24;12(1):1158
pubmed: 33627648
Am J Clin Pathol. 2004 Sep;122(3):359-69
pubmed: 15362365
Haematologica. 2017 Apr;102(4):656-665
pubmed: 28011901
Folia Histochem Cytobiol. 2015;53(1):62-9
pubmed: 25736845
Nature. 2017 Mar 2;543(7643):108-112
pubmed: 28225753
Am J Med. 1967 Jun;42(6):891-8
pubmed: 6067457
J Immunol. 2015 Jul 15;195(2):661-71
pubmed: 26085683
Blood. 2013 Jan 17;121(3):546-55
pubmed: 23212518
J Chromatogr A. 2017 Nov 24;1525:116-125
pubmed: 29061473
PLoS One. 2013 Jul 02;8(7):e67084
pubmed: 23843985
Crit Rev Oncog. 2013;18(3):197-220
pubmed: 23510064
Blood Rev. 2017 Nov;31(6):349-361
pubmed: 28669393
Stem Cells. 2014 Sep;32(9):2338-49
pubmed: 24801745
Blood. 2015 Jan 15;125(3):542-52
pubmed: 25411427
Blood Adv. 2018 Oct 23;2(20):2581-2587
pubmed: 30305267
J Cell Mol Med. 2020 Sep;24(17):9726-9736
pubmed: 32767726
Arch Pathol Lab Med. 2004 Oct;128(10):1191-2
pubmed: 15387692
Am J Hematol. 2015 Jul;90 Suppl 1:S6-11
pubmed: 26096746
Am J Hematol. 2010 Jul;85(7):472-6
pubmed: 20575041
Blood. 2003 Oct 15;102(8):2862-7
pubmed: 12829590
Am J Hematol. 2017 Sep;92(9):E561-E563
pubmed: 28621801
J Cell Physiol. 2018 Sep;233(9):6425-6440
pubmed: 29319160
Medicine (Baltimore). 1985 Sep;64(5):310-22
pubmed: 4033409
N Engl J Med. 2016 Feb 11;374(6):555-61
pubmed: 26863356
Haematologica. 2018 Apr;103(4):587-596
pubmed: 29305416
Mol Immunol. 2017 Aug;88:58-68
pubmed: 28600970
Hematology. 2005 Apr;10(2):151-6
pubmed: 16019462
Cardiovasc Res. 2007 Feb 1;73(3):470-80
pubmed: 17084825
Blood Adv. 2017 May 26;1(14):875-886
pubmed: 29296731
Baillieres Clin Haematol. 1997 Dec;10(4):657-89
pubmed: 9497857
Cytometry B Clin Cytom. 2011 Jan;80(1):28-37
pubmed: 20568298
Sci Transl Med. 2014 Jun 11;6(240):240ra73
pubmed: 24920659
J Leukoc Biol. 2011 Jan;89(1):159-71
pubmed: 20884648
N Engl J Med. 1991 May 23;324(21):1464-70
pubmed: 2023606
Arch Pathol. 1970 Feb;89(2):137-53
pubmed: 4312335
Lancet. 2008 Oct 4;372(9645):1263-71
pubmed: 19094956
J Inherit Metab Dis. 2011 Feb;34(1):233-5
pubmed: 21113739
Front Physiol. 2014 Jan 30;5:9
pubmed: 24523696
Inflammation. 2018 Aug;41(4):1361-1371
pubmed: 29680907
Blood. 2015 Feb 19;125(8):1256-71
pubmed: 25499455
Blood Cells Mol Dis. 2014 Dec;53(4):171-5
pubmed: 25153906
Proc Natl Acad Sci U S A. 2012 Oct 30;109(44):18054-9
pubmed: 23071332